Daniel E Lage
Overview
Explore the profile of Daniel E Lage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lage D, Blinderman C, Grudzen C
JCO Oncol Pract
. 2024 Sep;
21(2):107-109.
PMID: 39226488
To break the cycle of "rehabbed to death" in oncology, we must focus on improving communication and care coordination.
2.
Lage D, Burger A, Cohn J, Hernand M, Jin E, Horick N, et al.
J Pain Symptom Manage
. 2024 Aug;
68(6):613-621.e1.
PMID: 39197695
Context: Patients with advanced cancer are at increased risk for multiple hospitalizations and often have considerable needs postdischarge. Interventions to address patients' needs after transitioning home are lacking. Objectives: We...
3.
Johnson P, Woyach J, Ulrich A, Marcotte V, Nipp R, Lage D, et al.
J Geriatr Oncol
. 2023 Jun;
14(6):101538.
PMID: 37329769
Introduction: Chronic lymphocytic leukemia (CLL) commonly affects older adults. However, few studies have examined the relationship between baseline geriatric domains and clinical outcomes in this population. Here, we aim to...
4.
Graham L, Lin J, Lage D, Kessler E, Parikh R, Morgans A
Am Soc Clin Oncol Educ Book
. 2023 May;
43:e390396.
PMID: 37207299
The majority of men with prostate cancer are diagnosed when they are older than 65 years; however, clinical trial participants are disproportionately younger and more fit than the real-world population...
5.
Briggs L, Sentana-Lledo D, Lage D, Trinh Q, Morgans A
Ther Adv Med Oncol
. 2022 Dec;
14:17588359221141306.
PMID: 36531831
The burden of cancer and oncologic treatment is reflected not only through morbidity and mortality, but also through impacts on patient quality of life (QoL). However, QoL has not been...
6.
Lage D, Keating N, Temel J
JCO Oncol Pract
. 2022 May;
18(7):e1056-e1059.
PMID: 35549305
No abstract available.
7.
Chow R, Lage D, Williams G, Sedrak M, Greer J, Temel J, et al.
J Natl Compr Canc Netw
. 2022 Jan;
20(1):37-44.
PMID: 34991068
Background: Older adults account for 70% of cancer-related deaths, but previous studies have shown that they are underrepresented in cancer clinical trials. We sought to analyze the representation and outcomes...
8.
9.
Lage D, Michaelson M, Lee R, Greer J, Temel J, Sweeney C
Prostate Cancer Prostatic Dis
. 2021 May;
24(4):1181-1188.
PMID: 34007017
Background: Most men who die of prostate cancer are older than 70 years. The ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED) randomized men...
10.
Lage D, El-Jawahri A, Fuh C, Newcomb R, Jackson V, Ryan D, et al.
J Natl Compr Canc Netw
. 2020 Jun;
18(6):747-754.
PMID: 32502982
Background: National guidelines recommend regular measurement of functional status among patients with cancer, particularly those who are elderly or high-risk, but little is known about how functional status relates to...